• Table of Contents

    May 7, 2026, 10:05

  • Incremental Direct Cost of Chronic Obstructive Pulmonary Disease in Colombia Using Doubly Robust Methods on Administrative Data

    May 1, 2026, 00:00

  • Economic Impact of Self-Injected Biologics for Rheumatoid Arthritis in Japan: A Propensity Score-Matched Analysis From a Public Healthcare Payer Perspective

    May 1, 2026, 00:00

  • Cost-Effectiveness of Resmetirom for Metabolic Dysfunction-Associated Steatohepatitis in Brazil

    May 1, 2026, 00:00

  • Economic Evaluation and Budget Impact of Biosimilar Trastuzumab for HER2-Positive Metastatic Breast Cancer in Thailand: Policy Implications for Access and Affordability

    May 1, 2026, 00:00

  • Comparative Assessment of Short Form 6-Dimension Health State Preferences Among Lebanese Population Pre- and Post-COVID-19 Pandemic

    May 1, 2026, 00:00

  • Assessing the Impact of a Social Program Using EQ-HWB-9 and EQ-5D-5L: The Dara Project

    May 1, 2026, 00:00

  • Psychometric Performance of EQ-HWB and EQ-HWB-9 Self-Complete and Interviewer-Administered Versions in Literate, Low-Literacy, and Patient Populations in Indonesia

    May 1, 2026, 00:00

  • Custo-Efetividade da Teriparatida em Homens com Osteoporose Grave no Brasil

    May 1, 2026, 00:00

  • Cost-Utility Analysis of Add-On Vericiguat to Standard Treatment in Thai Patients With Heart Failure and Reduced Ejection Fraction

    May 1, 2026, 00:00

  • Evaluating the Performance of Claude 3.7 Sonnet in Data Extraction Automation for Systematic Literature Reviews

    May 1, 2026, 00:00

  • Long-Term Changes in Health-Related Quality of Life and Economic Burden After a SARS-CoV-2 Infection: Analysis of the Long COVID Prospective Cohort Study in Nairobi

    May 1, 2026, 00:00

  • Improving Access to Nuclear Medicine in Island Regions: A Cost-Minimization Analysis of Radiopharmaceutical Supply Strategies

    May 1, 2026, 00:00

  • Cost-Effectiveness of Vascular Endothelial Growth Factor Inhibitors in the Management of Wet Age-Related Macular Degeneration: A Systematic Review

    May 1, 2026, 00:00

  • Patient Preferences for Radiology Appointments and Factors Influencing Attendance Adherence: A Discrete Choice Experiment in Singapore Based on Behavioral Economics

    May 1, 2026, 00:00

  • Editorial Board

    May 1, 2026, 00:00

  • Real-World Data on Cervical Cancer: The Impact of 2020 COVID-19 Outbreak on the Treatment Patterns and Healthcare Resources Utilization in Brazilian Public Health System

    Mar 1, 2026, 00:00

  • Scaling-Up Nutrition: A Benefit-Cost and Cost-Effectiveness Analysis of Increasing Coverage of Nutrition Interventions in the Republic of Yemen

    Mar 1, 2026, 00:00

  • Table of Contents

    Mar 1, 2026, 00:00

  • Navigating the Transition to Value-Based Healthcare in Saudi Arabia: A Qualitative Study of Policy-Maker Perspectives

    Mar 1, 2026, 00:00

  • Expanding the Utility of Vision-Specific Instruments in Thai Health Economic Evaluation: Reflections on Mapping Impact of Vision Impairment Questionnaire to EQ-5D-5L

    Mar 1, 2026, 00:00

  • Team Learning in Head and Neck Surgery: An Economic and Quality Management Perspective

    Mar 1, 2026, 00:00

  • The Association Between Patient-Reported Experience Measures and Patient-Reported Outcome Measures Among Patients With Diabetes in the Kingdom of Saudi Arabia

    Mar 1, 2026, 00:00

  • The Economic Burden of Foodborne Diseases in Singapore

    Mar 1, 2026, 00:00

  • Cost Comparison of 2 Different Targets for Glycemic Control in Women With Gestational Diabetes: Evaluation From the TARGET Stepped-Wedge Randomized Trial

    Mar 1, 2026, 00:00

  • A Randomized Online Grocery Store Trial to Test a Salient Tiered Food and Beverage Tax in Saudi Arabia

    Mar 1, 2026, 00:00

  • The Economic Burden of Maternal Death in Jordan From 2018 to 2021: Social and Geographic Variations

    Mar 1, 2026, 00:00

  • Mapping the Children’s Dermatology Life Quality Index Questionnaire to EQ-5D-Y-3L in Pediatric Patients With Atopic Dermatitis

    Mar 1, 2026, 00:00

  • Exploring the Dual Dimensions: Economic Burden and Social Support Among Patients With Schizophrenia in Saudi Arabia

    Mar 1, 2026, 00:00

  • Editorial Board

    Mar 1, 2026, 00:00

  • Analysis of Mortality Trajectory Patterns in the Middle East and North Africa: Which Diseases Are the Deadliest?

    Mar 1, 2026, 00:00

  • Economic Burden and Cost-Effectiveness of Cancer Care in Ethiopia: A Systematic Review

    Mar 1, 2026, 00:00

  • The Impact of Care Burden of Young Carers on Their Preference for Social Supports

    Mar 1, 2026, 00:00

  • Economic Burden of Ischemic Heart Disease in Morocco: Evidence From a Teaching Hospital, a Cost-of-Illness Study

    Mar 1, 2026, 00:00

  • RWD303 The Impact of Care Burden of Young Carers on Their Preference for Social Supports

    Mar 1, 2026, 00:00

  • Toward Value-Based Healthcare in the Arabian Gulf and Wider Regions: New Evidence and Future Directions

    Mar 1, 2026, 00:00

  • Current Generics Utilization and Associated Savings in Saudi Arabia: Insights From a Private Claims Database

    Mar 1, 2026, 00:00

  • Evaluating the Factor Structure of the Preliminary Version of EuroQol Health and Well-Being Instrument in China: A Replication of the Confirmatory Factor Analysis

    Jan 1, 2026, 00:00

  • Latin American and Caribbean Trends and Health Priorities in Cost-Effectiveness Studies: A Bibliometric Analysis in Scopus in the 21st Century

    Jan 1, 2026, 00:00

  • Valuation of EQ-5D Health States for Adults in Low-, Lower-Middle, and Upper-Middle-Income Countries: A Systematic Review

    Jan 1, 2026, 00:00

  • Averting Cancer: The Economic Case for Expanding HPV Vaccination

    Jan 1, 2026, 00:00

  • Disparities in Out-of-Pocket Expenditures Among Hospitalized Patients With COVID-19 in Iran: A Decomposition Analysis of Inequality

    Jan 1, 2026, 00:00

  • Reducing the Travel Burden for Patients to Access Specialized Medicines in Paraná, Brazil

    Jan 1, 2026, 00:00

  • Author Reply

    Jan 1, 2026, 00:00

  • Table of Contents

    Jan 1, 2026, 00:00

  • Cost-Effectiveness of Text Messaging to Reengage Culturally and Linguistically Diverse Communities to Breast Cancer Screening: A Modeling Study

    Jan 1, 2026, 00:00

  • Cost-Analysis of Adherence to Antimicrobial Guidelines as Part of Antimicrobial Stewardship Strategies in 6 Latin American Countries: A Pilot Experience Focusing on Economic Impact

    Jan 1, 2026, 00:00

  • Real-World Effectiveness and Cost-Utility Analysis of Second-Line Immunotherapy for Non-Oncogene-Addicted Advanced Non-Small Cell Lung Cancer

    Jan 1, 2026, 00:00

  • Person-Centered Intervention for People Living With HIV in the Philippines: A Cost-Effective Approach for Resource Allocation Decisions

    Jan 1, 2026, 00:00

  • Prevention of Heart Failure With Icosapent Ethyl Results in Cost-Savings in the Spanish Population With Established Cardiovascular Disease

    Jan 1, 2026, 00:00

  • What Role Does Equity Play in Australia’s Health Technology Assessment Processes? A Review of the Pharmaceutical Benefits Advisory Committee Recommendations Regarding Vaccines

    Jan 1, 2026, 00:00

  • A Framework for Patient Prioritization in Bariatric Surgery Using a Predictive Success Score Versus a First-In First-Out Approach: A Cost-Effectiveness Analysis

    Jan 1, 2026, 00:00

  • Translation and Testing Psychometric Properties of the Thai Version of Vision Bolt-On EQ-5D in Patients With Visual Impairment

    Jan 1, 2026, 00:00

  • Editorial Board

    Jan 1, 2026, 00:00

  • Adapting a Benefit Trade-Off Instrument to Measure Health Inequality Aversion in the United States

    Jan 1, 2026, 00:00

  • Learning From Local Contexts: Practical Pathways Toward Health Equity

    Jan 1, 2026, 00:00

  • From Model to Clinic: Practical Considerations for Applying the Chinese Diabetes Risk Score in Prediabetes Screening

    Jan 1, 2026, 00:00

  • Public Preferences for Reducing Health Inequality in Japan: A National Survey

    Jan 1, 2026, 00:00

  • Editorial Board

    Nov 5, 2025, 08:27

  • Comparison of Cancer Registry Data Between Sweden and China and the Impact on Real-World Health Research

    Nov 1, 2025, 00:00

  • Cost Analysis of Diabetes Mellitus Treatment in the Public Sector in Dubai, The United Arab Emirates: Analysis Based on a Global Perspective Model

    Nov 1, 2025, 00:00

  • Cost-Effectiveness Analysis Comparing Ceftazidime/Avibactam With Standard of Care in the Treatment of Hospital and Ventilator-Acquired Pneumonia in the Philippines

    Nov 1, 2025, 00:00

  • Medicines Policy in Action: The Impact on Volume and Cost of Biologic Medicines After Biosimilar Introduction

    Nov 1, 2025, 00:00

  • Cost-Utility Analysis of Expanding Human Papillomavirus Vaccination to Adult Women in Indonesia: A Markov Model Approach

    Nov 1, 2025, 00:00

  • Table of Contents

    Nov 1, 2025, 00:00

  • Self-Reported Health-Related Quality of Life in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions

    Nov 1, 2025, 00:00

  • Impact of Severe Hemophilia on Costs and Quality of Life in South American Men: Findings From the CHESS LATAM Study

    Nov 1, 2025, 00:00

  • Epidemiology, Real-World Treatment, and Economic Burden of Waldenström Macroglobulinemia: A Comprehensive Analysis Based on Anonymized Claims Data Between 2010 and 2022

    Nov 1, 2025, 00:00

  • Healthcare Costs and Main Characteristics of Childbirth and Neonatal Inpatient Care From the Brazilian Public Health System Perspective

    Nov 1, 2025, 00:00

  • Cost and Budget Impact of Layering Depression Care Onto Existing HIV and Noncommunicable Disease Care Services in Western Kenya

    Nov 1, 2025, 00:00

  • Psychometric Validation of EQ-5D-5L in Individuals With Chronic Spinal Cord Injury in China

    Nov 1, 2025, 00:00

  • Correction

    Nov 1, 2025, 00:00

  • Disseminated Histoplasmosis in People Living With HIV: What Are the Care Costs for Brazil?

    Nov 1, 2025, 00:00

  • Predicting the EQ-5D-5L Utility Scores From the Impact of Vision Impairment Questionnaire in Thai Patients

    Nov 1, 2025, 00:00

  • Valuation of the Alzheimer’s Disease 5 Dimensions Instrument: A Discrete Choice Experiment With Life Duration in Chile

    Nov 1, 2025, 00:00

  • Disclaimer

    Oct 23, 2025, 09:07

  • RWD247 GEOGRAPHIC DISPARITIES IN ACCESS TO NATIONALLY NEGOTIATED ANTICANCER MEDICINES IN CHINA

    Oct 1, 2025, 00:00

  • RWD138 A PRACTICAL APPROACH TO IDENTIFYING EARLY NEONATAL CONDITIONS IN A DE-IDENTIFIED DATABASE: NATIONAL HEALTH INSURANCE RESEARCH DATABASE (NHIRD)

    Oct 1, 2025, 00:00

  • RWD161 COMPARISON OF RISK PREDICTION MODELS FOR KIDNEY DISEASE: AN EXTERNAL VALIDATION USING 0.5 MILLION UK BIOBANK PARTICIPANTS

    Oct 1, 2025, 00:00

  • RWD225 COST-EFFECTIVENESS OF DOCETAXEL VERSUS IMMUNE CHECKPOINT INHIBITORS AS TREATMENT FOR ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER: A TARGETED LITERATURE REVIEW

    Oct 1, 2025, 00:00

  • RWD122 COST-EFFECTIVENESS ANALYSIS OF PRENATAL DIAGNOSTIC STRATEGIES AMONG KOREAN PREGNANT WOMEN

    Oct 1, 2025, 00:00

  • RWD188 ADOPTION AND CHALLENGES OF ELECTRONIC CLINICAL OUTCOME ASSESSMENTS AND PATIENT-REPORTED OUTCOMES IN CHINA: INSIGHTS FROM A SURVEY OF HEALTHCARE PROFESSIONALS AND INDUSTRY STAKEHOLDERS

    Oct 1, 2025, 00:00

  • RWD185 CAREGIVERS’ ACCEPTANCE AND PERSPECTIVES ON AN AUGMENTED REALITY-BASED PRESSURE ULCER ASSESSMENT DEVICE: A QUALITATIVE STUDY BASED ON THE TECHNOLOGY ACCEPTANCE MODEL

    Oct 1, 2025, 00:00

  • RWD24 ACCEPTANCE OF REAL-WORLD EVIDENCE IN HTA IN JAPAN: IS THE POTENTIAL BEING REALIZED?

    Oct 1, 2025, 00:00

  • RWD63 METHOD OF AN EPIDEMIOLOGICAL RISK STUDY IN TENS OF THOUSANDS PATIENTS WITH WEARABLE CARDIOVERTER DEFIBRILLATOR FOR PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE PATIENTS WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION

    Oct 1, 2025, 00:00

  • RWD105 A REVIEW OF THE CHALLENGES AND OPPORTUNITIES FOR THE USE OF REAL-WORLD EVIDENCE FOR MEDICAL DEVICES IN JAPAN

    Oct 1, 2025, 00:00

  • RWD184 FNEURONET: A SEX-SPECIFIC DEEP LEARNING FRAMEWORK FOR AUTISM SPECTRUM DISORDER (ASD) AND ATTENTION DEFICIT AND HYPERACTIVITY DISORDER (ADHD) CLASSIFICATION IN FEMALE COHORTS BASED ON RESTING-STATE FMRI IMAGES

    Oct 1, 2025, 00:00

  • RWD280 THE LONG-TERM EFFECTS OF OPIOID USE BEFORE TOTAL JOINT REPLACEMENT SURGERY: A DOSE-RESPONSE TRIAL EMULATION USING NEW ZEALAND LINKED ADMINISTRATIVE DATA

    Oct 1, 2025, 00:00

  • RWD284 THE ASSOCIATION BETWEEN ANNUAL HOUSEHOLD INCOME AND TOTAL MONTHLY AMOUNT OF OUT-OF-POCKET MEDICAL EXPENSES PATIENTS ARE WILLING TO PAY AMONG PATIENTS OF INFERTILITY IN JAPAN: A CROSS-SECTIONAL PATIENT SURVEY

    Oct 1, 2025, 00:00

  • RWD106 PREDICTION OF RARE DISEASE MEDICATION TRANSITION PATTERNS BASED ON AN INTERPRETABLE MACHINE LEARNING MODEL

    Oct 1, 2025, 00:00

  • RWD18 ANALYSIS OF HEALTH-RELATED QUALITY OF LIFE AND ITS INFLUENCING FACTORS IN CHINESE PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY

    Oct 1, 2025, 00:00

  • RWD171 RESEARCH ON STAKEHOLDER COLLABORATION MECHANISM FOR MEDICAL DATA SHARING: A THREE-PARTY EVOLUTIONARY GAME ANALYSIS

    Oct 1, 2025, 00:00

  • RWD239 ADVANCING COLORECTAL CANCER (CRC) RESEARCH IN JAPAN: INSIGHTS FROM ELECTRONIC HEALTH RECORD (EHR)-DERIVED DATA IN JAPAN

    Oct 1, 2025, 00:00

  • RWD282 REAL-WORLD PATIENT CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS IN JAPAN: A RETROSPECTIVE CLAIMS ANALYSIS

    Oct 1, 2025, 00:00

  • RWD268 IMPACT OF MEDICAL INSURANCE PRICE NEGOTIATION POLICY ON INNOVATION OF CHINESE LISTED PHARMACEUTICAL COMPANIES: DIFFERENCE-IN-DIFFERENCES ANALYSIS

    Oct 1, 2025, 00:00

  • RWD82 LEVERAGING REAL-WORLD DATA (RWD) TO INFORM DRUG REIMBURSEMENT IN ASIA-PACIFIC: ADDRESSING CHALLENGES AND BUILDING SOLUTIONS

    Oct 1, 2025, 00:00

  • RWD126 UNDERSTANDING REAL-WORLD CLINICAL AND ECONOMIC BURDEN OF DIFFERENT DEVICES STRATEGIES FOR THE ENDOVASCULAR TREATMENT OF SYMPTOMATIC PERIPHERAL ARTERIAL DISEASE IN JAPAN: A REAL-WORLD CLAIMS DATA ANALYSIS PROTOCOL

    Oct 1, 2025, 00:00

  • RWD308 DOES IMPROVED HOSPITAL MANAGEMENT ENHANCE HEALTHCARE EFFICIENCY? EVIDENCE FROM COUNTY-LEVEL HOSPITALS IN CHINA

    Oct 1, 2025, 00:00

  • RWD261 MYASTHENIA GRAVIS HEALTHCARE RESOURCE USE AND COST OF THERAPY IN AUSTRALIA

    Oct 1, 2025, 00:00

  • RWD192 IMPLEMENTATION OF OSTEOPOROSIS SCREENING IN HONG KONG: PERSPECTIVES OF HEALTHCARE PROVIDERS THROUGH THE LENS OF THE CONSOLIDATED FRAMEWORK FOR IMPLEMENTATION RESEARCH

    Oct 1, 2025, 00:00

  • RWD149 ECONOMIC IMPLICATIONS OF GENERIC POMALIDOMIDE ADOPTION IN THE MANAGEMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: A BUDGET IMPACT ANALYSIS AT THE JALISCO INSTITUTE OF CANCEROLOGY

    Oct 1, 2025, 00:00

  • RWD159 PREFERENCES AND WILLINGNESS TO PAY FOR MAINTENANCE INHALERS AMONG ADULTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THAILAND: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD107 CHARACTERISTICS AND ACCESSIBILITY OF ORPHAN DRUGS THROUGH 2017-2024 NATIONAL DRUG PRICE NEGOTIATION IN CHINA

    Oct 1, 2025, 00:00

  • RWD292 PREFERENCE FOR VIRTUAL REALITY EXERGAME IN WEIGHT CONTROL SETTING AMONG YOUNG ADULTS: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD224 PREVALENCE AND ADVANCED SYSTEMIC TREATMENT PRESCRIPTION PATTERNS FOR SCALP PSORIASIS IN THE REAL-WORLD DERMATOLOGY SETTING IN THE UNITED STATES

    Oct 1, 2025, 00:00

  • RWD41 REAL-WORLD EVIDENCE OF THE EFFECTIVENESS AND SAFETY OF FIRST-LINE THERAPIES OF HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD304 PREVALENCE OF INFLUENZA VACCINATION UPTAKE AND HEALTH ATTITUDES AMONG ADULTS IN CHINA: A CHINA NATIONAL HEALTH AND WELLNESS SURVEY STUDY

    Oct 1, 2025, 00:00

  • RWD142 ANALYSIS OF IMPLEMENTATION AND TERMINATION CHARACTERISTICS OF MANAGED ENTRY AGREEMENTS FOR NEW DRUGS UNDER TAIWAN’S NATIONAL HEALTH INSURANCE SYSTEM

    Oct 1, 2025, 00:00

  • RWD260 A COMPARATIVE ANALYSIS OF THE REDAPT SYSTEM IN REVISION TOTAL HIP ARTHROPLASTY: EVIDENCE FROM A LARGE US CLAIMS DATABASE

    Oct 1, 2025, 00:00

  • RWD128 INCORPORATING REAL-WORLD DATA AND MATHEMATICAL MODELING TO ESTIMATE THE UNDIAGNOSED CHRONIC HEPATITIS B POPULATION

    Oct 1, 2025, 00:00

  • RWD69 HEALTHCARE COSTS AND RESOURCE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA: A NATIONWIDE POPULATION-BASED STUDY IN TAIWAN, 2017–2022

    Oct 1, 2025, 00:00

  • RWD274 ECONOMIC EVALUATION OF USING A UNIT DOSE DISPENSING ROBOT IN A THAI TERTIARY HOSPITAL

    Oct 1, 2025, 00:00

  • RWD77 HEALTHCARE UTILIZATION PATTERNS IN EARLY-STAGE BREAST CANCER TAIWANESE PATIENTS: A REAL WORLD EVIDENCE-BASED SUBTYPE-SPECIFIC STUDY

    Oct 1, 2025, 00:00

  • RWD281 LEVERAGING NATIONWIDE HEALTH AND INSURANCE RECORDS TO TRACK BIOLOGIC DRUG DIFFUSION IN IBD: A 20-YEAR REAL-WORLD STUDY FROM ISRAEL

    Oct 1, 2025, 00:00

  • Peer Reviewers

    Oct 1, 2025, 00:00

  • RWD270 ENHANCING CAUSAL DISCOVERY IN CHRONIC DISEASES: THE MAGIC FRAMEWORK USING MULTIPLE LLMS

    Oct 1, 2025, 00:00

  • RWD146 ASSOCIATION BETWEEN FRAILTY STATUS AND GLYCEMIC CONTROL IN MIDDLE-AGED AND OLDER ADULTS WITH TYPE 2 DIABETES: A CROSS-SECTIONAL ANALYSIS OF THE UK BIOBANK COHORT

    Oct 1, 2025, 00:00

  • RWD315 COST-EFFECTIVENESS OF CLINICAL BREAST EXAMINATION AS SCREENING MODALITY FOR BREAST CANCER IN VIETNAM: A MARKOV MODELLING

    Oct 1, 2025, 00:00

  • RWD298 PUBLIC HEALTH IMPACT ASSESSMENT OF RSVPREF3 OA ADJUVANTED VACCINE ON RESPIRATORY SYNCYTIA VIRUS IN TAIWAN, HONG KONG, AND SINGAPORE

    Oct 1, 2025, 00:00

  • RWD112 ECONOMIC EVALUATION OF SELUMETINIB FOR TREATING PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 INOPERABLE PLEXIFORM NEUROFIBROMAS IN THAILAND

    Oct 1, 2025, 00:00

  • RWD238 UTILIZATION OF BIOPSY PRIOR LUNG RESECTION: A RETROSPECTIVE ANALYSIS USING JAPAN'S MEDICAL DATA VISION DATABASE (2008-2023)

    Oct 1, 2025, 00:00

  • RWD198 ESTIMATING THRESHOLD FOR GOOD QUALITY OF LIFE IN AGED CARE RESIDENTS: ANCHOR-BASED CUT-OFF FOR THE QUALITY OF LIFE-AGED CARE CONSUMERS INSTRUMENT

    Oct 1, 2025, 00:00

  • RWD38 PRESCRIPTION PATTERN AND COSTS OF ANTIDIABETIC MEDICATIONS IN PATIENTS WITH TYPE 2 DIABETES BY SPECIALIST PHYSICIANS AND NON-SPECIALIST PHYSICIANS

    Oct 1, 2025, 00:00

  • RWD23 RESEARCH ON THE DRIVING MECHANISM OF CORPORATE PARTICIPATION IN GOVERNANCE FOR HEALTH—AN EMPIRICAL ANALYSIS BASED ON CHINESE LISTED COMPANIES

    Oct 1, 2025, 00:00

  • RWD236 THE HEALTH-RELATED QUALITY OF LIFE, RENAL DYSFUNCTION AND BLADDER STONE ODDS AMONG INDIVIDUALS WITH SPINAL CORD INJURY WITH DIFFERENT BLADDER EMPTYING METHODS SURVEYED ACROSS CHINA: AN EXPLORATORY ANALYSES FROM TWO NATIONAL SURVEYS

    Oct 1, 2025, 00:00

  • RWD143 ARTIFICIAL INTELLIGENCE ADOPTION IN CLINICAL PRACTICE IN CHINA: PATTERNS AND CHALLENGES

    Oct 1, 2025, 00:00

  • RWD285 COST-UTILITY ANALYSIS OF ECULIZUMAB FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) IN THAILAND

    Oct 1, 2025, 00:00

  • RWD237 EVALUATING THE HEALTH IMPACT AND COST-EFFECTIVENESS OF GENDER-NEUTRAL VACCINATION OF 9-VALENT HUMAN PAPILLOMAVIRUS VACCINE IN THE PHILIPPINES USING A DYNAMIC TRANSMISSION MODEL

    Oct 1, 2025, 00:00

  • RWD103 CHARACTERISTICS AND APPLICATIONS OF BODY SIZE DATA IN JAPANESE CLAIMS DATABASES

    Oct 1, 2025, 00:00

  • RWD48 THE IMPACT OF ENTERAL NUTRITION ON THE SHORT-TERM AND SURVIVAL OUTCOMES OF LUNG CANCER AND BREAST CANCER PATIENTS UNDERGOING MEDICAL TREATMENT

    Oct 1, 2025, 00:00

  • RWD186 A QUALITATIVE STUDY ON OBESE ADULTS’ PERCEPTIONS OF USING ARTIFICIAL INTELLIGENCE FOR WEIGHT MANAGEMENT COUNSELING

    Oct 1, 2025, 00:00

  • RWD44 COMPARATIVE EFFICACY AND SAFETY OF SODIUM PICOSULFATE AND POLYETHYLENE GLYCOL IN CHINESE POPULATION: A META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD67 ASSOCIATIONS BETWEEN SLEEP DURATION AND LIFESTYLE BEHAVIORS AMONG ADOLESCENTS IN HONG KONG: A CROSS-SECTIONAL STUDY

    Oct 1, 2025, 00:00

  • RWD256 COMPARATIVE EFFECTS OF SMOKING CESSATION INTERVENTION FOR ADOLESCENTS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD70 IMPACT OF CHILD MALTREATMENT ON HEALTH-RELATED QUALITY OF LIFE: FINDINGS FROM THE AUSTRALIAN LONGITUDINAL STUDY ON WOMEN’S HEALTH

    Oct 1, 2025, 00:00

  • RWD95 COST OF ILLNESS ANALYSIS OF SELF-INJECTION OF BIOLOGICS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN JAPAN

    Oct 1, 2025, 00:00

  • RWD120 PRESCRIPTION TRENDS FOR ADHD MEDICATIONS IN JAPAN, 2018-2023

    Oct 1, 2025, 00:00

  • RWD31 ASSESSING ADOPTION AND FEASIBILITY OF THE HONG KONG REFERENCE FRAMEWORK FOR PREVENTIVE CARE IN OLDER ADULTS: A CROSS-SECTIONAL SURVEY OF PRIMARY CARE PRACTITIONERS

    Oct 1, 2025, 00:00

  • RWD233 CHARACTERISTICS OF AUSTRALIAN PBAC SUBMISSIONS USING RWE

    Oct 1, 2025, 00:00

  • RWD216 REAL-WORLD STUDY ON TREATMENT PATTERNS AND ECONOMIC BURDEN OF DIABETIC PERIPHERAL NEUROPATHIC PAIN IN CHINA

    Oct 1, 2025, 00:00

  • RWD99 ASSESSING THE SOCIOECONOMIC IMPACT OF DUCHENNE MUSCULAR DYSTROPHY ON CARER’S LIFE IN AUSTRALIA: A CROSS-SECTIONAL STUDY

    Oct 1, 2025, 00:00

  • RWD226 MULTIDIMENSIONAL BURDEN OF NEUROFIBROMATOSIS TYPE 1 (NF1): A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2025, 00:00

  • RWD98 GENOME-WIDE AND PHENOME-WIDE ANALYSES TO IDENTIFY HIGH-RISK PROFILES FOR TYPE 1 DIABETES

    Oct 1, 2025, 00:00

  • RWD115 COST-EFFECTIVENESS OF BUPROPION FOR SELF-CARE ADHERENCE AND GLYCAEMIC CONTROL IN MULTIMORBID TYPE 2 DIABETES MELLITUS AND MILD DEPRESSION [ADHERE-DM] – A CROSS-OVER RANDOMIZED CONTROLLED TRIAL-BASED ECONOMIC EVALUATION

    Oct 1, 2025, 00:00

  • RWD231 IMPACT OF CHILD MALTREATMENT ON THE COSTS OF HEALTH SERVICE USE AND PRODUCTIVITY LOSS: FINDINGS FROM THE AUSTRALIAN CHILD MALTREATMENT STUDY

    Oct 1, 2025, 00:00

  • RWD319 AN EMPIRICAL STUDY ON THE DISCOUNTING RATE OF PHARMACOECONOMIC EVALUATIONS IN CHINA

    Oct 1, 2025, 00:00

  • RWD125 INTEGRATING REAL WORLD EVIDENCE IN ECONOMIC EVALUATION OF HERPES ZOSTER VACCINATION AMONG KIDNEY TRANSPLANT PATIENTS IN THAILAND

    Oct 1, 2025, 00:00

  • RWD118 DESIGNING A PHYSICIAN CAPACITY-BASED PAYMENT FRAMEWORK UNDER A GLOBAL BUDGET: INSIGHTS FROM PHYSICIAN-LEVEL CLAIMS DATA

    Oct 1, 2025, 00:00

  • RWD73 THE SOCIO-ECONOMIC BURDEN OF END-STAGE KIDNEY DISEASE: REAL-WORLD EVIDENCE FROM BULGARIA

    Oct 1, 2025, 00:00

  • RWD249 CRYOBALLOON VERSUS RADIOFREQUENCY ABLATION IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Oct 1, 2025, 00:00

  • RWD79 SEX DIFFERENCES IN THE NATIONWIDE INCIDENCE OF NEURODEVELOPMENTAL DISORDERS AMONG CHILDREN IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD242 PROPOSAL OF USING CLAIMS-BASED DIAGNOSES AND PRENATAL EXAMINATIONS TO IDENTIFY PREGNANCY IN TAIWAN: NATIONAL HEALTH INSURANCE RESEARCH DATABASE

    Oct 1, 2025, 00:00

  • RWD78 BURDEN OF INTRAVENOUS IMMUNOGLOBULIN USE AMONG ADULTS WITH GENERALIZED MYASTHENIA GRAVIS IN JAPAN

    Oct 1, 2025, 00:00

  • RWD75 USING REAL WORLD DATA TO ESTIMATE THE COST OF CARDIAC IMPLANTABLE ELECTRONIC DEVICE (CIED) INFECTION IN A HIGH-RISK AUSTRALIAN POPULATION

    Oct 1, 2025, 00:00

  • RWD293 COST-EFFECTIVENESS OF DOSTARLIMAB FOR ADVANCED OR RECURRENT MSI-H/DMMR ENDOMETRIAL CANCER IN ANTI-PD1/PD-L1 NAïVE PATIENTS: A TAIWAN'S NATIONAL HEALTH INSURANCE PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD10 PREFERENCES FOR ADOPTING ARTIFICIAL INTELLIGENCE IN RADIATION THERAPY TREATMENT: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD321 COST-EFFECTIVENESS OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL IN ELDERLY PATIENTS WITH SEVERE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    Oct 1, 2025, 00:00

  • RWD110 POLYPHARMACY AND RISK OF MAJOR CARDIOVASCULAR EVENTS AMONG CHINESE PATIENTS WITH DIABETES: A RETROSPECTIVE COHORT STUDY USING INSTRUMENTAL VARIABLE ANALYSIS

    Oct 1, 2025, 00:00

  • RWD148 GLOBAL LANDSCAPE OF NOVEL CLINICAL TRIAL DESIGNS: A CROSS-SECTIONAL ANALYSIS OF WHO REGISTERED TRIALS

    Oct 1, 2025, 00:00

  • RWD317 THE BURDEN OF JAPANESE ENCEPHALITIS IN THE ASIA-PACIFIC: INSIGHTS FROM REAL-WORLD DATA

    Oct 1, 2025, 00:00

  • RWD288 REHABILITATION FOR PATIENTS WITH CANCER: SURVIVAL OUTCOMES AND HEALTHCARE RESOURCE UTILIZATION BASED ON MULTICENTER CANCER REGISTRY AND ADMINISTRATIVE DATA IN JAPANESE REAL-WORLD SETTINGS

    Oct 1, 2025, 00:00

  • RWD93 REAL-WORLD EFFECTIVENESS OF ATEZOLIZUMAB-BEVACIZUMAB, LENVATINIB AND SORAFENIB IN THE PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA: A MULTI-INSTITUTIONAL STUDY IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD265 A REVIEW OF THE RECENT HISTORY OF THE USE OF RWE IN AUSTRALIAN PBAC DECISION MAKING

    Oct 1, 2025, 00:00

  • RWD14 ASSESSMENT OF STROKE PATTERNS AND RISK FACTORS IN NORTHEAST INDIA: A HOSPITAL-BASED PROSPECTIVE STUDY

    Oct 1, 2025, 00:00

  • RWD227 DAILY DOSES AND DURATION OF GABAPENTIN AND PREGABALIN USE FOR PAIN MANAGEMENT AMONG OPIOID USERS BELOW AND ABOVE 65 YEARS OLD: TRENDS AND PATTERNS

    Oct 1, 2025, 00:00

  • RWD312 CHANGING ETIOLOGY OF CIRRHOSIS AND OTHER CHRONIC LIVER DISEASES: IMPLICATIONS FOR HEPATOCELLULAR CARCINOMA SURVEILLANCE IN NON-CIRRHOTIC PATIENTS

    Oct 1, 2025, 00:00

  • RWD20 HOW CAN WE ENHANCE THE USE OF RWE IN REIMBURSEMENT DECISIONS? BEST PRACTICES AND RECOMMENDATIONS

    Oct 1, 2025, 00:00

  • RWD124 IDENTIFYING RISK-FACTORS ASSOCIATED WITH POSTPARTUM DEPRESSION THROUGH CLAIMS DATA IN JAPAN

    Oct 1, 2025, 00:00

  • RWD65 BALANCING INNOVATION AND AFFORDABILITY: HEALTH SYSTEM TRADE-OFFS IN THAILAND’S REIMBURSEMENT RESTRICTION POLICIES FOR HIGH-COST MEDICINES

    Oct 1, 2025, 00:00

  • RWD251 ASSOCIATION OF INITIAL Z-DRUG PRESCRIPTION DURATION AND LONG-TERM USE

    Oct 1, 2025, 00:00

  • RWD255 IMPORTANT FEATURES OF TELEREHABILITATION FOR MUSCULOSKELETAL PATIENTS: APPLYING AN IMPLEMENTATION SCIENCE FRAMEWORK TO INFORM THE SELECTION OF ATTRIBUTES FOR DISCRETE CHOICE EXPERIMENTS

    Oct 1, 2025, 00:00

  • RWD22 MINDFULNESS-BASED INTERVENTIONS FOR PSYCHOLOGICAL DISTRESS IN LUNG CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD323 UNLOCKING PREFERENCES FOR WORK-LIFE BALANCE AND FERTILITY POLICIES AMONG WORKING WOMEN IN EAST ASIA: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD218 OVERVIEW OF RARE DISEASE PATIENT-CENTERED STUDIES METHODOLOGIES AND RECOMMENDATIONS TO OVERCOME CHALLENGES

    Oct 1, 2025, 00:00

  • RWD253 FORECASTING SURVIVAL IN NASOPHARYNGEAL CANCER PATIENTS WITH DIABETES THROUGH MACHINE LEARNING: A POPULATION-BASED ANALYSIS

    Oct 1, 2025, 00:00

  • RWD85 PRICE VARIATIONS AMONG STANDARDIZED VOLUNTARY HEALTH INSURANCE PLANS: EVIDENCE FROM HONG KONG

    Oct 1, 2025, 00:00

  • RWD208 COST-UTILITY AND BUDGET IMPACT ANALYSIS OF FARICIMAB FOR DIABETIC MACULAR EDEMA (DME) AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) IN INDONESIA

    Oct 1, 2025, 00:00

  • RWD154 PREFERENCES AND WILLINGNESS TO PAY FOR MAMMOGRAPHY SCREENING SERVICES AMONG WORKING-AGE URBAN WOMEN IN THAILAND

    Oct 1, 2025, 00:00

  • RWD91 DIRECT MEDICAL COSTS OF NASOPHARYNGEAL CARCINOMA IN INDONESIA: A HEALTHCARE PAYER PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD40 EVALUATING THE REPRESENTATIVENESS OF A REAL-WORLD ONCOLOGY DATABASE DEVELOPED BY THE J-CONNECT CONSORTIUM: COMPARISON WITH JAPAN'S NATIONAL CANCER REGISTRY

    Oct 1, 2025, 00:00

  • RWD266 HEALTHCARE RESOURCE USE OF PEDIATRIC AND ADULT PATIENTS WITH SEIZURES ASSOCIATED WITH DRAVET SYNDROME, LENNOX-GASTAUT SYNDROME, OR TUBEROUS SCLEROSIS COMPLEX IN JAPAN

    Oct 1, 2025, 00:00

  • RWD235 THE SOCIO-ECONOMIC BURDEN OF TERMINAL CANCER: REAL-WORLD EVIDENCE FROM BULGARIA

    Oct 1, 2025, 00:00

  • RWD92 STATIN USE AND THE PROGRESSION OF PARKINSON’S DISEASE: A POPULATION-BASED COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD140 REAL-WORLD UTILIZATION, PERSISTENCE, AND EFFECTIVENESS OF BIOLOGIC THERAPIES IN PATIENTS WITH SEVERE ASTHMA: A MULTICENTER RETROSPECTIVE COHORT STUDY IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD89 ASSESSING EARLY ADOPTION OF PULSED FIELD ABLATION FOR THE TREATMENT OF ATRIAL FIBRILLATION USING CLAIMS AND HOSPITAL CHARGE DATA

    Oct 1, 2025, 00:00

  • RWD204 COMPARATIVE OUTCOMES OF INDWELLING PERITONEAL CATHETERS (IPCS) VERSUS LARGE VOLUME PARACENTESIS (LVP) IN THE MANAGEMENT OF MALIGNANT AND NON-MALIGNANT ASCITES: A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2025, 00:00

  • RWD66 HEALTH-RELATED QUALITY OF LIFE AND ITS DETERMINANTS AMONG INDIVIDUALS WITH SPINAL CORD INJURY IN CHINA: EXPLORATORY ANALYSES FROM TWO NATIONAL SURVEYS

    Oct 1, 2025, 00:00

  • RWD30 DETERMINANTS OF WILLINGNESS TO ACCEPT THE PNEUMOCOCCAL VACCINE: AN POPULATION-BASED STUDY IN HONG KONG

    Oct 1, 2025, 00:00

  • RWD59 THE HEALTHCARE AND ECONOMIC BURDEN ASSOCIATED WITH INADEQUATE RISK FACTOR CONTROL FOR TYPE 2 DIABETES IN HONG KONG: A POPULATION-BASED MODELLING STUDY

    Oct 1, 2025, 00:00

  • RWD297 REAL-WORLD EVIDENCE USE IN JAPANESE HTA: INSIGHTS FROM MANUFACTURER SUBMISSIONS AND PUBLIC ANALYSES (2019-2025)

    Oct 1, 2025, 00:00

  • RWD94 ASSOCIATION BETWEEN USE OF A MULTIDISCIPLINARY NURSE- AND ALLIED HEALTH-LED MANAGEMENT SERVICE FOR COPD AND SUBSEQUENT HOSPITALIZATION DUE TO AMBULATORY CARE SENSITIVE CONDITIONS

    Oct 1, 2025, 00:00

  • RWD248 DRUG SURVIVAL, SWITCHING PATTERN, AND COSTS OF MODERATE TO SEVERE PSORIASIS PATIENTS TREATED WITH BIOLOGICS IN CHINA

    Oct 1, 2025, 00:00

  • RWD68 ASSESSMENT OF SEASONAL VARIATION IN THE PERFORMANCE OF FECAL IMMUNOCHEMICAL TESTING FOR COLORECTAL CANCER SCREENING

    Oct 1, 2025, 00:00

  • RWD176 EVALUATING FIT-FOR-PURPOSE ANONYMIZATION STRATEGIES FOR JAPANESE REAL-WORLD DATA UNDER EU DATA PROTECTION STANDARDS

    Oct 1, 2025, 00:00

  • RWD76 POTENTIAL RISK OF ACUTE PANCREATITIS WITH GLP-1 RECEPTOR AGONISTS

    Oct 1, 2025, 00:00

  • RWD84 PATIENT VOICES IN HEALTH TECHNOLOGY ASSESSMENTS: INSIGHTS FROM AUSTRALIA AND SINGAPORE

    Oct 1, 2025, 00:00

  • RWD276 EXPLORING THE ASSOCIATIONS BETWEEN NEWER GLUCOSE-LOWERING DRUGS USE AND COGNITIVE FUNCTION DECLINE IN ADULTS WITH DIABETES: A TARGET TRIAL EMULATION

    Oct 1, 2025, 00:00

  • RWD90 ESTIMATING THE LIFETIME SURVIVAL AND QALYS OF TUMOR-TREATING FIELDS IN COMBINATION WITH TEMOZOLOMIDE FOR GLIOBLASTOMA USING A KOREAN POPULATION

    Oct 1, 2025, 00:00

  • RWD86 PRELIMINARY REPORT OF SYSTEM DYNAMICS MODELING OF A CO-PAYMENT MECHANISM FOR BREAST CANCER PATIENTS IN MALAYSIA

    Oct 1, 2025, 00:00

  • RWD302 UTILIZATION OF PATIENT-EXPERIENCED DATA IN HEALTH TECHNOLOGY ASSESSMENTS IN ASIA PACIFIC REGION

    Oct 1, 2025, 00:00
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »